January - March 2018: 
Volume 31, Issue 1

Click on the image to download the Issue in PDF format.


Pneumon 2018, 31(1):24-34
Biomedical Applications of Biopolymers in Airway Disease
Authors Information
1School of Mathematical and Natural Sciences, Arizona State University, Glendale AZ, USA,
2Department of Chemistry, Laboratory of Biochemistry, Aristotle University, Thessaloniki, Greece

1.  Bugnicourt E, Cinelli P, Lazzeri A, et al. Polyhydroxyalkanoate (PHA): Review of synthesis, characteristics, processing and potential applications in packaging. In. Vol 8. eXPRESS Polymer Letters 2014:791-808.

2.  Khandal D, Pollet E, Avérous L. Polyhydroxyalkanoate-based Multiphase Materials. In: The Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge CB4 0WF, UK; 2014:119-40.

3.  Luef KP, Stelzer F, Wiesbrock F. Poly(hydroxy alkanoate)s in Medical Applications. Chem Biochem Eng Q 2015; 29:287-97.

4.  Cheema U, Ananta M, Mudera V. Collagen: Applications of a Natural Polymer in Regenerative Medicine. In. Vol ISBN 978-953-307-663-8. Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 2011.

5.  Pantazaki AA, Papaneophytou CP, Pritsa AG, et al. Production of polyhydroxyalkanoates from whey by Thermus thermophilus HB8. In. Vol 44. Process Biochemistry 2009.

6.  Pantazaki AA, Papaneophytou CP, Lambropoulou DA. Simultaneous polyhydroxyalkanoates and rhamnolipids production by Thermus thermophilus HB8. AMB Express 2011;1:17.

7.  Pantazaki AA, Choli-Papadopoulou T. On the Thermus thermophilus HB8 potential pathogenicity triggered from rhamnolipids secretion: morphological alterations and cytotoxicity induced on fibroblastic cell line. Amino Acids 2012; 42:1913-26.

8.  Chen G. Plastics Completely Synthesized by Bacteria: Polyhydroxyalkanoates. In. Chen GQ. (eds) Plastics from Bacteria. Microbiology Monographs, vol 14. Springer, Berlin, Heidelberg 2009.

9.  Koller M. Advances in Polyhydroxyalkanoate (PHA) Production. Bioengineering (Basel). 2017;4.

10.  Koller M, Maršálek L, de Sousa Dias MM, et al. Producing microbial polyhydroxyalkanoate (PHA) biopolyesters in a sustainable manner. N Biotechnol 2017; 37(Pt A):24-38.

 11.  Anjum A, Zuber M, Zia KM, et al. Microbial production of polyhydroxyalkanoates (PHAs) and its copolymers: A review of recent advancements. Int J Biol Macromol 2016;89:161-74.

12.  Chen GQ, Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 2005;26:6565-78.

13.  Gilding DK, Reed AM. Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1. In. Vol 20. Polymer 1979:1459-64.

14.  Middleton JC, Tipton AJ. Synthetic Biodegradable Polymers as Medical Devices. In. Medical Plastics and Biomaterials Magazine: Retrieved 2006-07-04.; 1998.

15.  Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-83.

16.  Sugihara H, Toda S, Miyabara S, et al. Reconstruction of alveolus-like structure from alveolar type II epithelial cells in three-dimensional collagen gel matrix culture. Am J Pathol 1993;142:783-92.

17.  Chen P, Marsilio E, Goldstein RH, et al. Formation of lung alveolar-like structures in collagen-glycosaminoglycan scaffolds in vitro. Tissue Eng 2005;11:1436-48.

18.  Andrade CF, Wong AP, Waddell TK, et al. Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol 2007;292:L510-18.

19.  Mondrinos MJ, Koutzaki S, Lelkes PI, et al. A tissue-engineered model of fetal distal lung tissue. Am J Physiol Lung Cell Mol Physiol 2007; 293:L639-50.

20.  Nichols JE, Niles JA, Vega SP, et al. Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use. Exp Biol Med (Maywood) 2014;239:1135-69.

21.  Coraux C, Nawrocki-Raby B, Hinnrasky J, et al. Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 2005;32:87-92.

22.  Silveyra P, Chroneos ZC, Di Angelo SL, et al. Knockdown of Drosha in human alveolar type II cells alters expression of SP-A in culture: a pilot study. Exp Lung Res 2014;40:354-66.

23.  Noutsios GT, Willis AL, Ledford JG, et al. Novel role of surfactant protein A in bacterial sinusitis. Int Forum Allergy Rhinol 2017;7:897-903.

24.  Key Statistics for Lung Cancer. In. Jan 5, 2017 ed: American Cancer Society; 2017.

25.  Fonseca AC, Serra AC, Coelho JF. Bioabsorbable polymers in cancer therapy: latest developments. EPMA J 2015;6:22.

26.  Jain KK. Drug delivery systems - an overview. Methods Mol Biol 2008;437:1-50.

27.  Sankar R, Karthik S, Subramanian N, et al. Nanostructured delivery system for suberoylanilide hydroxamic acid against lung cancer cells. Mater Sci Eng C Mater Biol Appl 2015;51:362-8.

28.  Shi Y, Zhou M, Zhang J, et al. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles. J Microencapsul 2015; 32:699-704.

29.  Yang N, Jiang Y, Zhang H, et al. Active targeting docetaxel-PLA nanoparticles eradicate circulating lung cancer stem-like cells and inhibit liver metastasis. Mol Pharm 2015;12:232-9.

30.  Long JT, Cheang TY, Zhuo SY, et al. Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis. J Nanobiotechnology 2014;12:37.

31.  Bhushan B, Khanadeev V, Khlebtsov B, et al. Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery. Adv Colloid Interface Sci 2017;246:13-39.

32.  Zhang F, Zhang S, Pollack SF, et al. Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers. J Am Chem Soc 2015;137:2056-66.

33.  Chang EH, Willis AL, McCrary HC, et al. Association between the CDHR3 rs6967330 risk allele and chronic rhinosinusitis. J Allergy Clin Immunol 2016.

34.  Vankeerberghen A, Cuppens H, Cassiman JJ. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros 2002;1:13-29.

35.  Fajac I, Briand P, Monsigny M, et al. Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum Gene Ther 1999; 10:395-406.

36.  Ziady AG, Kelley TJ, Milliken E, et al. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther 2002;5:413-9.

37.  Cunningham S, Meng QH, Klein N, et al. Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J Gene Med 2002;4:438-46.

38.  Konstan M, Wagener J, Hilliard K, et al. Single Dose Escalation Study To Evaluate Safety of Nasal Administration of CFTR001 Gene Transfer Vector to Subjects with Cystic Fibrosis. In. Vol 7. Mol Ther2003.

39.  Koehler DR, Hannam V, Belcastro R, et al. Targeting transgene expression for cystic fibrosis gene therapy. Mol Ther 2001;4:58-65.

40.  Alton EWFW, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015;3:684-91.

41.  Noutsios GT, Floros J. Highlights of Early Pulmonary Surfactant: Research from Bench to Clinic. In. Vol 26. Pneumon2013.

42.  Long W, Thompson T, Sundell H, et al. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. J Pediatr 1991;118(4 Pt 1):595-605.

43.  Lu JJ, Yu LM, Cheung WW, et al. Poly(ethylene glycol) (PEG) enhances dynamic surface activity of a bovine lipid extract surfactant (BLES). Colloids Surf B Biointerfaces 2005;41:145-51.

44.  Kobayashi T, Ohta K, Tashiro K, et al. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol (1985) 1999;86:1778-84.

45.  Lu KW, Goerke J, Clements JA, et al. Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury. Pediatr Res 2005;58:206-10.

46.  Zuo YY, Alolabi H, Shafiei A, et al. Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation. Pediatr Res 2006;60:125-30.

47.  López-Rodríguez E, Ospina OL, Echaide M, et al. J. Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer. Biophys J 2012;103:1451-9.

48.  Gregory AE, Titball R, Williamson D. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013;3:13.

49.  Lü JM, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009;9:325-41.

50.  Sonaje K, Chuang EY, Lin KJ, et al. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm 2012;9:1271-9.

51.  Uto T, Akagi T, Toyama M, et al. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice. Immunol Lett 2011;140:36-43.

52.  Mohr E, Cunningham AF, Toellner KM, et al. IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci U S A 2010;107:17292-7.

53.  Qiu S, Wei Q, Liang Z, et al. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen. Hum Vaccin Immunother 2014;10:2350-56.

54.  Foged C, Brodin B, Frokjaer S, et al. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005;298:315-22.

55.  Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009;26:244-9.

56.  Bivas-Benita M, Lin MY, Bal SM, et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine 2009;27:4010-17.

57.  Bowald SF, Johansson-Ruden EG. A novel surgical material. In. European Patent Application No. 0 349 505 A2.1997.

58.  Malm T, Bowald S, Bylock A, et al. Enlargement of the right ventricular outflow tract and the pulmonary artery with a new biodegradable patch in transannular position. Eur Surg Res 1994;26:298-308.

59.  Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102(19 Suppl 3):III44-9.

60.  Stock UA, Sakamoto T, Hatsuoka S, et al. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg 2000;120:1158-67; discussion 1168.

61.  Mettler BA, Sales VL, Stucken CL, et al. Stem cell-derived, tissue-engineered pulmonary artery augmentation patches in vivo. Ann Thorac Surg 2008;86:132-40; discussion 140-31.

62.  Calvo-Mendezab C, Ruiz-Herreraab J. Biosynthesis of chitosan in membrane fractions from Mucor rouxii by the concerted action of chitin synthetase and a particulate deacetylase. In. Vol 11. Experimental Mycology 1987:128-40.

63.  Kääpä E, Han X, Holm S, et al. Collagen synthesis and types I, III, IV, and VI collagens in an animal model of disc degeneration. Spine (Phila Pa 1976) 1995;20:59-66; discussion 66-57.

64.  Arpicco S, Canevari S, Ceruti M, et al. Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids. Farmaco 2004;59:869-878.

65.  Rohanizadeh R, Swain MV, Mason RS. Gelatin sponges (Gelfoam) as a scaffold for osteoblasts. J Mater Sci Mater Med 2008;19:1173-82.

66.  Taokaew S, Seetabhawang S, Siripong P, et al. Biosynthesis and Characterization of Nanocellulose-Gelatin Films. Materials (Basel) 2013;6:782-94.

67.  Sugahara K, Schwartz NB, Dorfman A. Biosynthesis of hyaluronic acid by Streptococcus. J Biol Chem 1979;254:6252-61.

68.  Maura K. Maintenance of the EHS sarcoma and Matrigel preparation. In. Vol 161994:227–30.

69.  Song Z, Zhang R, Lu H, et al. Synthesis and Biomedical Applications of Polyamino Acids. In. Vol 8.3. Material Matters 2016:78.

70.  Tauhardt L, Kempe K, Knop K, et al. Linear Polyethyleneimine: Optimized Synthesis and Characterization – On the Way to “Pharmagrade” Batches. In. Vol 212. Macromol Chem Phys 2011:1918–24.

71.  Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci 2014;15:3640-59.

72.  Hamano Y, Kito N, Kita A, et al. ε-Poly-L-lysine peptide chain length regulated by the linkers connecting the transmembrane domains of ε-Poly-L-lysine synthetase. Appl Environ Microbiol 2014;80:4993-5000.

73.  Robbins PW, Wright A, Dankert M. Polysaccharide biosynthesis. J Gen Physiol 1966;49:331-46.

74.  Lu Y, Yin L, Zhang Y, et al. Synthesis of water-soluble poly(α-hydroxy acids) from living ring-opening polymerization of O-benzyl-L-serine carboxyanhydrides. ACS Macro Lett 2012;1:441-4.